Full-Time

Director – Gxp Quality Assurance and Compliance

Confirmed live in the last 24 hours

Schrödinger

Schrödinger

501-1,000 employees

Computational platform for drug discovery research

Enterprise Software
Biotechnology
Healthcare

Compensation Overview

$185k - $235kAnnually

Senior

Cambridge, MA, USA + 1 more

More locations: New York, NY, USA

Category
QA & Testing
Quality Assurance
Required Skills
Google Cloud Platform
Requirements
  • Bachelor's degree in life sciences (Master’s degree in life sciences preferred)
  • Twelve to fifteen years of Quality Assurance experience in the pharmaceutical or biotech industry, with at least five years in a leadership role
  • Technical quality experience preferred
  • Experience in manufacturing operations preferred
  • Expert level knowledge of GMP regulations and FDA requirements, Guidance documents, and industry best practices, with a focus on Analytical/QC testing
  • Good working knowledge of global GxP standards, including USP/Ph., FDA/EMA, and ICH
  • History of success with the management of inspections performed by the FDA and other regulatory bodies
  • Excellent written and oral communication skills
  • Ability to travel domestically and internationally on occasion
Responsibilities
  • Design, develop and implement overall GxP Quality Assurance strategy and vision for Schrödinger’s Therapeutics Group
  • Develop, implement, and manage the continuous improvement of robust quality management systems, including, *e.g.*, vendor management, deviation management, change control, CAPAs, product label review, risk management, and eQMS (MasterControl)
  • Ensure compliance, in collaboration with relevant SMEs and senior leaders, with all applicable GxP regulations, including GMP, GCP, and GLP
  • Establish key quality system metrics and process indicators to proactively identify and address quality systems or product issues
  • Oversee the development and implementation of all relevant training programs to ensure staff are knowledgeable about GxP requirements and quality standards
  • Provide leadership and guidance to teams on inspection readiness, including hosting and participating in regulatory inspections (GMP, BIMO, etc.)
  • Account for appropriate oversight of all vendors, including CDMOs and CROs, to ensure regulatory compliance
  • Serve as spokesperson and technical subject matter quality expert for all matters governed by GMP-related regulations/guidelines and industry best practices (*e.g.*, FDA, EMA, PMDA, etc.)
  • Perform and manage day-to-day GMP QA activities
  • Author, review, and approve all relevant GMP quality documents

Schrödinger provides a computational platform that aids in the research efforts of biopharmaceutical companies, academic institutions, and government laboratories around the world. Their platform offers advanced computational tools that help in drug discovery and development across various therapeutic areas. Schrödinger's products work by utilizing sophisticated algorithms and simulations to predict how different compounds will interact, which can significantly speed up the research process. Unlike many competitors, Schrödinger not only licenses its software but also engages in collaborative drug discovery programs, allowing them to work closely with clients on specific projects. The company's goal is to enhance scientific research and innovation by providing powerful tools and resources that support the development of new therapies.

Company Stage

IPO

Total Funding

$362.7M

Headquarters

New York City, New York

Founded

1990

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Simplify Jobs

Simplify's Take

What believers are saying

  • Schrödinger received a $10M grant to expand predictive toxicology tools.
  • The discovery of SGR-1505 showcases Schrödinger's platform efficiency in drug discovery.
  • Schrödinger's focus on ESG matters enhances corporate reputation and stakeholder trust.

What critics are saying

  • Increased competition from Recursion and Exscientia merger in AI drug discovery.
  • Avicenna's ML-enhanced platform could outpace Schrödinger's capabilities.
  • High cost and complexity of drug discovery could strain Schrödinger's resources.

What makes Schrödinger unique

  • Schrödinger's platform supports diverse clients, including biopharmaceutical companies and academic institutions.
  • The company engages in both wholly-owned and collaborative drug discovery programs.
  • Schrödinger's computational tools are used in over 70 countries worldwide.

Help us improve and share your feedback! Did you find this helpful?